Has Abbott Stock's Valuation Shifted With Expanded FDA Approvals in 2025? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
The stock is up 9.8% year-to-date, despite a recent 6.9% dip in the last month. This highlights how sentiment and risk perception can change quickly. Investors have been reacting to headline-grabbing developments such as innovations in Abbott's medical device segment and new product launches, as well as broader healthcare trends. For example, recent news about expanded FDA approvals and international partnerships has added energy to the stock, even as the broader sector faces regulatory shifts. Based on our valuation checks, Abbott Laboratories scores a 3 out of 6 for being undervalued, giving us some clear signals. As we explore different approaches to valuation below, stay tuned for a more nuanced way to interpret these numbers at the end of the article. Abbott Laboratories delivered 8.6% returns over the last year. See how this stacks up to the rest of the Medical Equipment industry. Approach 1: Abbott Laboratories Discounted Cash Flow (DCF) Analysis A Discounted Cash Fl
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Is Abbott Laboratories Fairly Priced After Growth In Devices And Diagnostics? [Yahoo! Finance]Yahoo! Finance
- Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement [Yahoo! Finance]Yahoo! Finance
- Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health MovementPR Newswire
- 7 deaths linked to faulty blood glucose monitors as FDA issues safety warning [FOX Business Network]FOX Business Network
- UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/3/25 - Form SCHEDULE
- 11/25/25 - Form 4
- 11/25/25 - Form 144
- ABT's page on the SEC website